Oaktree Acquisition III Life Sciences Operating Income 2025-2024 | OACC
Oaktree Acquisition III Life Sciences operating income from 2025 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Oaktree Acquisition III Life Sciences Annual Operating Income (Millions of US $) |
|---|
| Oaktree Acquisition III Life Sciences Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-09-30 | |
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PicoCELA (PCLA) | Japan | $0.173B | 0.00 |
| Aduro Clean Technologies (ADUR) | Canada | $0.156B | 0.00 |
| Range Capital Acquisition (RANG) | United States | $0.140B | 0.00 |
| Tavia Acquisition (TAVI) | $0.139B | 0.00 | |
| CO2 Energy Transition (NOEM) | $0.095B | 0.00 | |
| Leishen Energy Holding (LSE) | China | $0.089B | 0.00 |
| YHN Acquisition I (YHNA) | $0.081B | 0.00 | |
| Youxin Technology (YAAS) | $0.065B | 0.00 | |
| YSX Tech (YSXT) | China | $0.062B | 0.00 |
| New Century Logistics (BVI) (NCEW) | Hong Kong, SAR China | $0.026B | 0.00 |
| Hong Kong Pharma Digital Technology Holdings (HKPD) | $0.019B | 0.00 | |
| Sky Quarry (SKYQ) | $0.016B | 0.00 | |
| Flowco Holdings (FLOC) | $0.000B | 0.00 |